| Íàèìåíîâàíèå | Ïðîèçâîäèòåëü | Öåíà $ | Öåíà ðóá
|
|---|
| Ð-Ð ÄËß ÊÎÍÒÀÊÒÍÛÕ ËÈÍÇ RENU MULTIPLUS 120 ÌË. Õ1 | BAUSCH & LOMB | | 170.36
|
| Ð-Ð ÄËß ÊÎÍÒÀÊÒÍÛÕ ËÈÍÇ RENU MULTIPLUS 240 ÌË. Õ1 | BAUSCH & LOMB | | 272.12
|
| Ð-Ð ÄËß ÊÎÍÒÀÊÒÍÛÕ ËÈÍÇ RENU MULTIPLUS 355 ÌË. Õ1 | BAUSCH & LOMB | | 330.39
|
| ÐÀÄÅÂÈÒ ÌÀÇÜ 35 Ã. Õ1 | ÐÅÒÈÍÎÈÄÛ | | 235.05
|
| ÐÀÍÈÒÈÄÈÍ ÒÀÁË. 150 ÌÃ Õ20 | ÎÇÎÍ | | 9.91
|
| ÐÀÍÈÒÈÄÈÍ ÒÀÁË. 150 ÌÃ Õ60 | SOPHARMA | | 74.85
|
| ÐÅÀÔÅÐÎÍ-ÅÑ Ð-Ð 5000000 ÌÅ ÀÌÏ. Õ5 | ÂÅÊÒÎÐ-ÌÅÄÈÊÀ | | 1683.18
|
| ÐÅÂÀËÃÈÍ Ð-Ð ÀÌÏ. 5 ÌË. (ÁÀÐÀËÃÈÍ) Õ5 | SHREYA | | 67.77
|
| ÐÅÂÀËÃÈÍ ÒÀÁË. (ÁÀÐÀËÃÈÍ) Õ20 | SHREYA | | 40.1
|
| ÐÅÂÈÒ ÄÐÀÆÅ Õ100 | ÔÀÐÌÑÒÀÍÄÀÐÒ ÓÔÀÂÈÒÀ | | 10.34
|
| ÐÅÃÈÄÐÎÍ ÏÎÐ. ÄÎÇ. Õ20 | ORION CORPORATION | | 434.43
|
| ÐÅËÈÔ ÀÄÂÀÍÑ ÌÀÇÜ ÐÅÊÒÀËÜÍ. ÒÓÁÀ 28.4 Ã. Õ1 | SAGMEL INC | | 153.29
|
| ÐÅËÈÔ ÀÄÂÀÍÑ ÑÂÅ×È Õ12 | SAGMEL INC/INSTITUTO DE A | | 177.45
|
| ÐÅËÈÔ ÑÂÅ×È Õ12 | SAGMEL INC/INSTITUTO DE A | | 167.16
|
| ÐÅËÈÔ ÓËÜÒÐÀ ÑÂÅ×È Õ12 | SAGMEL INC | | 177.4
|
| ÐÅËÏÀÊÑ ÒÀÁË. Ï/Î 40 ÌÃ Õ2 | PFIZER | | 278.33
|
| ÐÅÌÅÍÑ ÊÀÏËÈ ÔË. 50 ÌË. Õ1 | BITTNER RICHARD GMBH | | 339.03
|
| ÐÅÍÈÏÐÈË ÒÀÁË. 10 ÌÃ Õ20 | ÔÀÐÌÑÒÀÍÄÀÐÒ ËÅÊÑÐÅÄÑÒÂÀ | | 45.42
|
| ÐÅÍÈÏÐÈË ÒÀÁË. 20 ÌÃ Õ20 | ÔÀÐÌÑÒÀÍÄÀÐÒ ËÅÊÑÐÅÄÑÒÂÀ | | 59.01
|
| ÐÅÍÈÏÐÈË ÃÒ ÒÀÁË. Õ20 | ÔÀÐÌÑÒÀÍÄÀÐÒ ËÅÊÑÐÅÄÑÒÂÀ | | 67.03
|
| ÐÅÍÈÒÅÊ ÒÀÁË. 10 ÌÃ Õ14 | MERCK SHARP & DOHME | | 96.84
|
| ÐÅÍÈÒÅÊ ÒÀÁË. 20 ÌÃ Õ14 | MERCK SHARP & DOHME | | 215.16
|
| ÐÅÍÈÒÅÊ ÒÀÁË. 5 ÌÃ Õ14 | MERCK SHARP & DOHME | | 64.83
|
| ÐÅÍÍÈ /ÌÅÍÒÎË/ ÒÀÁË. ÆÅÂ. Õ12 | BAYER SANTE FAMILIALE | | 72
|
| ÐÅÍÍÈ /ÌÅÍÒÎË/ ÒÀÁË. ÆÅÂ. Õ24 | BAYER SANTE FAMILIALE | | 107.52
|
| ÐÅÍÍÈ /ÌßÒÀ/ ÒÀÁË. ÆÅÂ. (ÁÅÇ ÑÀÕÀÐÀ) Õ12 | BAYER SANTE FAMILIALE | | 69.04
|
| ÐÅÍÍÈ /ÌßÒÀ/ ÒÀÁË. ÆÅÂ. (ÁÅÇ ÑÀÕÀÐÀ) Õ24 | BAYER SANTE FAMILIALE | | 116.5
|
| ÐÅÎÏÎËÈÃËÞÊÈÍ ÔË. 400 ÌË. Õ1 | ÁÈÎÕÈÌÈÊ | | 82.53
|
| ÐÅÎÏÎËÈÃËÞÊÈÍ-40-ÝÑÊÎÌ ÔË. 200 ÌË. Õ1 | ÝÑÊÎÌ | | 80.98
|
| ÐÅÎÏÎËÈÃËÞÊÈÍ-40-ÝÑÊÎÌ ÔË. 400 ÌË. Õ1 | ÝÑÊÎÌ | | 110.87
|
| ÐÅÏÈÑÀÍ ÊÀÏËÈ ÔË. 20 ÌË. Õ1 | BITTNER RICHARD GMBH | | 98.48
|
| ÐÅÒÈÍÀËÀÌÈÍ ÏÎÐ. ËÈÎÔ. 5 ÌÃ Õ10 | ÃÅÐÎÔÀÐÌ | | 3479.74
|
| ÐÅÔÎÐÒÀÍ ÃÝÊ Ð-Ð 10 % 500 ÌË. Õ1 | BERLIN-CHEMIE AG/MENARINI | | 546.22
|
| ÐÅÔÎÐÒÀÍ ÃÝÊ Ð-Ð 6 % 250 ÌË. Õ1 | BERLIN-CHEMIE AG/MENARINI | | 291.25
|
| ÐÅÔÎÐÒÀÍ ÃÝÊ Ð-Ð 6 % 500 ÌË. Õ1 | BERLIN-CHEMIE AG/MENARINI | | 443.19
|
| ÐÅÔÎÐÒÀÍ ÃÝÊ Ð-Ð 6 % ÏËÀÑÒ. ÓÏ-ÊÀ 500 ÌË. Õ1 | BERLIN-CHEMIE AG/MENARINI | | 448.22
|
| ÐÈÁÀÂÈÐÈÍ ÊÀÏÑ. 200 ÌÃ Õ30 | ÎÇÎÍ | | 826.73
|
| ÐÈÁÀÂÈÐÈÍ ÒÀÁË. 200 ÌÃ Õ20 | ÊÀÍÎÍÔÀÐÌÀ ÏÐÎÄÀÊØÍ | | 329.26
|
| ÐÈÁÀÏÅÃ ÒÀÁË. 200 ÌÃ (ÐÈÁÀÂÈÐÈÍ) Õ60 | ÌÀÊÈÇ-ÔÀÐÌÀ | | 1299.95
|
| ÐÈÁÎÊÑÈÍ Ð-Ð 2 % ÀÌÏ. 10 ÌË. Õ10 | ÂÅÐÎÔÀÐÌ | | 30.37
|
| ÐÈÁÎÊÑÈÍ Ð-Ð 2 % ÀÌÏ. 10 ÌË. Õ10 | ÄÀËÜÕÈÌÔÀÐÌ | | 30.39
|
| ÐÈÁÎÊÑÈÍ Ð-Ð 2 % ÀÌÏ. 10 ÌË. Õ10 | ÍÎÂÎÑÈÁÕÈÌÔÀÐÌ | | 30.38
|
| ÐÈÁÎÊÑÈÍ Ð-Ð 2 % ÀÌÏ. 5 ÌË. Õ10 | ÁÎÐÈÑÎÂÑÊÈÉ ÇÀÂÎÄ | | 15.81
|
| ÐÈÁÎÊÑÈÍ Ð-Ð 2 % ÀÌÏ. 5 ÌË. Õ10 | ÔÅÐÅÉÍ | | 18.61
|
| ÐÈÁÎÌÓÍÈË ÃÐÀÍÓËßÒ ÏÀÊ. Õ4 | PIERRE FABRE | | 365.8
|
| ÐÈÃÅÂÈÄÎÍ ÒÀÁË. Õ21 | GEDEON RICHTER | | 110.38
|
| ÐÈÃÅÂÈÄÎÍ ÒÀÁË. Õ28 | GEDEON RICHTER | | 120.58
|
| ÐÈÃÅÂÈÄÎÍ ÒÀÁË. Õ84 | GEDEON RICHTER | | 320.92
|
| ÐÈËÅÏÒÈÄ ÒÀÁË. Ï/Î 2 ÌÃ Õ20 | EGIS | | 747
|
| ÐÈËÅÏÒÈÄ ÒÀÁË. Ï/Î 4 ÌÃ Õ20 | EGIS | | 1322.92
|
| ÐÈÍÃÅÐÀ Ð-Ð ÔË. 1000 ÌË. Õ1 | ÌÅÄÏÎËÈÌÅÐ | | 48.64
|
| ÐÈÍÃÅÐÀ Ð-Ð ÔË. 250 ÌË. (ÊÏ-1) Õ1 | ÌÅÄÏÎËÈÌÅÐ | | 26.89
|
| ÐÈÍÃÅÐÀ Ð-Ð ÔË. 500 ÌË. Õ1 | HEMOFARM | | 56.14
|
| ÐÈÍÃÅÐÀ Ð-Ð ÔË. 500 ÌË. Õ1 | ÌÅÄÏÎËÈÌÅÐ | | 33.92
|
| ÐÈÍÇÀ ËÎÐÑÅÏÒ /ÀÏÅËÜÑÈÍ/ ÒÀÁË. Ä/ÐÀÑÑÀÑ. Õ12 | UNIQUE PHARMACEUTICAL LAB | | 30.68
|
| ÐÈÍÇÀ ËÎÐÑÅÏÒ /ËÈÌÎÍ/ ÒÀÁË. Ä/ÐÀÑÑÀÑ. Õ12 | UNIQUE PHARMACEUTICAL LAB | | 33.28
|
| ÐÈÍÇÀ ÒÀÁË. ( ÎÒ ÃÐÈÏÏÀ È ÏÐÎÑÒÓÄÛ) Õ10 | UNIQUE PHARMACEUTICAL LAB | | 46.42
|
| ÐÈÍÇÀÑÈÏ /ÀÏÅËÜÑÈÍ/ ÏÀÊ. 5 Ã. Õ10 | UNIQUE PHARMACEUTICAL LAB | | 87.78
|
| ÐÈÍÇÀÑÈÏ /ÀÏÅËÜÑÈÍ/ ÏÀÊ. 5 Ã. Õ5 | UNIQUE PHARMACEUTICAL LAB | | 46.84
|
| ÐÈÍÇÀÑÈÏ /ËÈÌÎÍ/ ÏÀÊ. 5 Ã. Õ10 | UNIQUE PHARMACEUTICAL LAB | | 92.95
|
| ÐÈÍÇÀÑÈÏ /×ÅÐÍ.ÑÌÎÐÎÄÈÍÀ/ ÏÀÊ. 5 Ã. Õ5 | UNIQUE PHARMACEUTICAL LAB | | 50.76
|
| ÐÈÍÈÊÎËÄ ÒÀÁË. Õ10 | SHREYA | | 35.87
|
| ÐÈÍÈÊÎËÄ ÕÎÒÌÈÊÑ /ÀÏÅËÜÑÈÍ/ ÏÎÐ. ÑÀØÅ 5 Ã. Õ5 | SHREYA | | 44.04
|
| ÐÈÍÈÊÎËÄ ÕÎÒÌÈÊÑ /ËÈÌÎÍ/ ÏÎÐ. ÑÀØÅ 5 Ã. Õ5 | SHREYA | | 44.04
|
| ÐÈÍÎÍÎÐÌ ÑÏÐÅÉ Ä/ÍÎÑÀ (10ÌÃ/10ÌË) Õ1 | MERCKLE GMBH | | 67.01
|
| ÐÈÍÎÍÎÐÌ ÑÏÐÅÉ Ä/ÍÎÑÀ (5ÌÃ/10ÌË) Õ1 | MERCKLE GMBH | | 62.08
|
| ÐÈÍÎÑÒÎÏ 0.1 % ÔË./ÊÀÏ. ÏËÀÑÒ. 10 ÌË. Õ1 | ËÅÊÊÎ/ÌÀÑÒÅÐËÅÊ | | 10.44
|
| ÐÈÍÎÔËÓÈÌÓÖÈË ÀÝÐÎÇ. ÍÀÇ. 10 ÌË. Õ1 | ZAMBON | | 181.99
|
| ÐÎÂÀÌÈÖÈÍ ÒÀÁË. 3000000 ÌÅ Õ10 | FAMAR LION | | 342.14
|
| ÐÎÌÀÇÓËÀÍ Ð-Ð ÔË. 50 ÌË. Õ1 | BIOFARM S.A. | | 85.7
|
| ÐÎÌÀØÊÀ ÖÂÅÒÊÈ Â ÏÀ×ÊÅ 50 Ã. Õ1 | ÊÐÀÑÍÎÃÎÐÑÊ ËÅÊ ÑÐ-ÂÀ | | 28.9
|
| ÐÎÌÀØÊÀ ÖÂÅÒÊÈ Ô/Ï. 1.5 Ã. Õ20 | ÊÐÀÑÍÎÃÎÐÑÊ ËÅÊ ÑÐ-ÂÀ | | 26.71
|
| ÐÎÒÎÊÀÍ ÔË. 25 ÌË. Õ1 | ÂÈÔÈÒÅÕ | | 16.19
|
| ÐÎÒÎÊÀÍ ÔË. 50 ÌË. Õ1 | ßÐÎÑËÀÂÑÊÀß ÔÀÐÌ. ÔÀÁÐÈÊÀ | | 26.06
|
| ÐÓËÈÄ ÒÀÁË. 150 ÌÃ Õ10 | AVENTIS/ÈÍÒÅÐÊÎÍÒÈÍÅÍÒÀËÜ | | 350.77
|
| ÐÛÁÈÉ ÆÈÐ ÌÀÑËÎ ÎÐÀË. 50 ÌË. Õ1 | ÒÂÅÐÑÊÀß ÔÀÐÌ. ÔÀÁÐÈÊÀ | | 14.9
|
| ÐßÁÈÍÀ ÏËÎÄÛ Â ÏÀ×ÊÅ 100 Ã. Õ1 | ÊÐÀÑÍÎÃÎÐÑÊ ËÅÊ ÑÐ-ÂÀ | | 45.58
|